The First Fill Podcast 2025 Aug
Tracking # 20-1323626
$99999.00
There are no ratings for this course
Learn more Educator AMERICAN PHARMACISTS ASSOCIATION
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
0202-0000-25-207-H02-P / In this episode of The First Fill, we will review two recent new drug approvals, gepotidacin for UTI and lenacapavir for treatment and prevention of HIV. You'll hear about outcomes from clinical trials and patient counseling points for the new agents. In episode 2, an expert will discuss how pharmacists can improve care for people with HIV and how she sees lenacapavir impacting treatment and prevention.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Pharmacy
Pharmacist
0.5h
General